目的 :评价急危重疾病并心律失常静脉注射胺碘酮的疗效及安全性。方法 :选择急诊危重症并快速心律失常患者 2 3例 ,接受静脉注射胺碘酮治疗 ,根据心律失常转复为窦性心律 ,心率减慢、早搏减少和心律失常未纠正、心率未减慢分别评为显效、有效和无效。同时分析用药前后的血压和心率以及副作用。结果 :显效率 73 .9% ,有效率 2 6% ,无效率4%。结论 :危重症并快速心律失常静脉注射胺碘酮有效、安全 ,特别适用于缺血性心脏病并心功能不全患者 Objective: To evaluate the efficacy and safety of intravenous amiodarone in critically ill patients with arrhythmia. Methods: Twenty-three critically ill critically ill patients with tachyarrhythmia were enrolled in this study. Patients were given intravenous amiodarone, and then converted to sinus rhythm according to arrhythmia. The heart rate was slowed down, the premature beat was reduced and the arrhythmia was not corrected. The heart rate did not slow down Rated as effective, effective and ineffective. At the same time analysis of blood pressure and heart rate before and after treatment and side effects. Results: Significant efficiency 73 .9%, effective 26%, inefficient 4%. Conclusions: Intravenous amiodarone in critically ill patients with tachyarrhythmia is effective and safe, especially for patients with ischemic heart disease and cardiac insufficiency